Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Baxter
Medtronic
Daiichi Sankyo
US Army
Chubb
Express Scripts
Cipla
McKinsey
AstraZeneca

Generated: August 23, 2017

DrugPatentWatch Database Preview

NABUMETONE Drug Profile

« Back to Dashboard

What is the patent landscape for Nabumetone, and when can generic versions of Nabumetone launch?

Nabumetone is a drug marketed by Chartwell Molecules, Mylan Pharms Inc, Dr Reddys Labs Ltd, Apotex Inc, Lupin Ltd, Invagen Pharms, Copley Pharm, Sandoz, Watson Labs, Impax Labs Inc, and Oxford Pharms. and is included in twelve NDAs.

The generic ingredient in NABUMETONE is nabumetone. There are twenty drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nabumetone profile page.

Summary for Tradename: NABUMETONE

Patents:0
Applicants:11
NDAs:12
Suppliers / Packagers: see list41
Bulk Api Vendors: see list59
Clinical Trials: see list9
Patent Applications: see list5,962
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NABUMETONE at DailyMed

Pharmacology for Tradename: NABUMETONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecules
NABUMETONE
nabumetone
TABLET;ORAL076009-001Jan 24, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
NABUMETONE
nabumetone
TABLET;ORAL075189-001May 26, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
NABUMETONE
nabumetone
TABLET;ORAL090427-001Dec 30, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
NABUMETONE
nabumetone
TABLET;ORAL090516-002Jul 12, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
NABUMETONE
nabumetone
TABLET;ORAL078671-002Mar 7, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Boehringer Ingelheim
Mallinckrodt
Fuji
US Army
Baxter
McKesson
Colorcon
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot